These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9393594)

  • 1. Synthesis of quantitation standards for nested competitive PCR for the determination of minimal residual disease in B-lineage acute lymphoblastic leukaemia.
    Martin G; Mairs RJ
    Leuk Res; 1997 Sep; 21(9):807-9. PubMed ID: 9393594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction-single-strand conformational polymorphism analysis of antigen receptor rearrangements in monitoring therapeutic effect in childhood ALL.
    Thunberg U; Sällström J; Frost BM; Lönnerholm G; Sundström C
    Diagn Mol Pathol; 1998 Jun; 7(3):146-51. PubMed ID: 9836069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
    Della Starza I; Cavalli M; De Novi LA; Genuardi E; Mantoan B; Drandi D; Barbero D; Ciabatti E; Grassi S; Gazzola A; Mannu C; Agostinelli C; Piccaluga PP; Bomben R; Degan M; Gattei V; Guarini A; Foà R; Galimberti S; Ladetto M; Ferrero S; Del Giudice I;
    Hematol Oncol; 2019 Oct; 37(4):368-374. PubMed ID: 31325190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual disease.
    Steward CG; Potter MN; Oakhill A
    Leukemia; 1992 Nov; 6(11):1213-9. PubMed ID: 1434806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia.
    Pfitzner T; Engert A; Wittor H; Schinköthe T; Oberhäuser F; Schulz H; Diehl V; Barth S
    Leukemia; 2000 Apr; 14(4):754-66. PubMed ID: 10764166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of minimal residual disease in childhood acute lymphoblastic leukaemia.
    Yeoh AE; Quah TC; Jeyaseelan K; Lee BW; Poh KS; Sun L
    Ann Acad Med Singap; 1997 May; 26(3):365-71. PubMed ID: 9285034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of minimal residual disease in B-cell lineage acute lymphoblastic leukemia of childhood, using clone-specific probes.
    Botsonis T; Tsangaris GT; Mikraki V; Tzortzatou-Stathopoulou F
    Anticancer Res; 1999; 19(3B):2211-20. PubMed ID: 10472333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
    Deane M; Norton JD
    Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved.
    Ouspenskaia MV; Johnston DA; Roberts WM; Estrov Z; Zipf TF
    Leukemia; 1995 Feb; 9(2):321-8. PubMed ID: 7869771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL.
    Chim JC; Coyle LA; Yaxley JC; Cole-Sinclair MF; Cannell PK; Hoffbrand VA; Foroni L
    Br J Haematol; 1996 Jan; 92(1):104-15. PubMed ID: 8562380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
    Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
    Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification.
    Deane M; Norton JD
    Br J Haematol; 1990 Mar; 74(3):251-6. PubMed ID: 2334634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR.
    Brüggemann M; Droese J; Bolz I; Lüth P; Pott C; von Neuhoff N; Scheuering U; Kneba M
    Leukemia; 2000 Aug; 14(8):1419-25. PubMed ID: 10942238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by the polymerase chain reaction.
    Potter MN; Steward CG; Maitland NJ; Oakhill A
    Leukemia; 1992 Apr; 6(4):289-94. PubMed ID: 1588791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
    Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
    Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.
    Uchiyama M; Maesawa C; Yashima A; Itabashi T; Satoh T; Tarusawa M; Endo M; Takahashi Y; Sasaki S; Tsuchiya S; Ishida Y; Masuda T
    J Clin Pathol; 2003 Dec; 56(12):952-5. PubMed ID: 14645357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
    Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
    Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of minimal residual disease in adult patients with B-lineage acute lymphoblastic leukemia using rearranged immunoglobulin loci detection].
    Yao L; Chen ZX; Cen JN; Liu H; He J; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jul; 31(7):433-7. PubMed ID: 21122394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin gene rearrangement in detection of minimal residual disease in acute lymphoblastic leukaemia.
    Nayyar A; Ahmed S
    J Ayub Med Coll Abbottabad; 2013; 25(1-2):159-61. PubMed ID: 25098084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias.
    Linke B; Pyttlich J; Tiemann M; Suttorp M; Parwaresch R; Hiddemann W; Kneba M
    Leukemia; 1995 May; 9(5):840-7. PubMed ID: 7769847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.